Functional peptides by genome reverse engineering

Computational biology and chemistry combined with high-throughput analytical technologies contribute to reduce operational costs and foster innovation in every phase of the discovery of bioactive molecules. In order for life science industries to continue to deliver at the required market rate, new concepts need to be implemented in research and development, and new sources of bioactive molecules should be investigated. The genomic revolution provides the necessary information to generate novel bioactive peptides by the computational dissection of genomes.